February 28, 2022
The 30 million Americans diagnosed with a rare disease represent a large, underserved patient population. Their complex conditions are often poorly understood, and most have no approved treatment.
February 24, 2022
As an aging America faces rising rates of obesity and diabetes, people may also find themselves facing a dangerous cardiovascular disease.
February 22, 2022
ICER has announced its intent to issue a final evidence report in this review without first holding a public hearing, a highly unusual decision.
February 17, 2022
Even after vowing to expand patients’ engagement in its process, the nation’s most active health technology assessment organization has shut them out.
February 17, 2022
Patients, alongside their health care providers, should decide which medication is right for them. Yet, with increasing frequency, that decision is being overruled by “the middleman.”
February 14, 2022
Most patients with cystic fibrosis are just wrapping up an annual hassle of the new year – that of confirming their insurance will still cover the medications they need. It’s a process known as insurance reauthorization.
February 11, 2022
Shared decision-making and a trusted physician-patient relationship are cornerstones of patient-centered care. Sometimes, however, health insurers can disrupt care by…
February 10, 2022
By Johana R. Fajardo, DNP, ANP-BC - I walk with many amyloidosis patients throughout their journey, from diagnosis to end of life.
February 8, 2022
Cancer touches people from all walks of life. But, too often, cutting-edge cancer treatments aren’t accessible to everyone equally.
February 4, 2022
Most Medicare beneficiaries could be blocked from accessing the first-of-its-kind therapy for Alzheimer’s disease, if a proposed rule goes into effect.
